Adjuvant Chemotherapy

Identifier: CI-DRUG-00000040
Entity page: /drug/adjuvant-chemotherapy ↗
Edges: 85

Neighbours: 15 cancers1 variants10 trials
Drawn: 26 of 26 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Adjuvant Chemotherapy predicts response to …PREDICTS_RESPONSE_TO1 of 1
← predicts response to	TP53 Wildtypeother	sensitivity	B	Lung Non-Small Cell Carcinoma	1	Curated	civic	graph →
Adjuvant Chemotherapy investigated for …INVESTIGATED_FOR1 of 1
investigated for

Adjuvant Chemotherapy investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 33show all (up to 200)
→ investigated in trials for	Malignant Colon Neoplasm 6 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Colon Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Breast Neoplasm 5 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Breast Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Gastric Neoplasm 5 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Gastric Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Ovarian Carcinoma 5 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Ovarian Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Rectal Neoplasm 4 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Rectal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Lung Non-Small Cell Carcinomasubtype 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Lung Non-Small Cell Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Fallopian Tube Neoplasm 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Fallopian Tube Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Primary Peritoneal Carcinoma 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Primary Peritoneal Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cervical Neoplasm 2 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Cervical Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Cervical Neoplasm 2 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Cervical Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Colorectal Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Colorectal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Ovarian Neoplasm 2 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Ovarian Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Pancreatic Neoplasm 2 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Pancreatic Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Rectal Neoplasm 2 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Rectal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Colon Neoplasm 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Colon Neoplasm	1	Observed	clinicaltrials	graph →

Adjuvant Chemotherapy investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 33show all (up to 200)

→ investigated in trials for

Malignant Colon Neoplasm

6 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Malignant Colon Neoplasm

Observed

Adjuvant Chemotherapy studied in …STUDIED_INderived10 of 50show all (up to 200)
→ studied in	NCT01817192NA · active not recruiting Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients) · 50 trials list this drug (21 active)	—	—	Lung Non-Small Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02676349Phase 2 · completed Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) · 50 trials list this drug (21 active)	—	—	Pancreatic Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05496491NA · recruiting Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial · 50 trials list this drug (21 active)	—	—	Rectal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06914440Phase 2 · recruiting Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer · 50 trials list this drug (21 active)	—	—	Malignant Breast Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06052332NA · recruiting Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer · 50 trials list this drug (21 active)	—	—	Malignant Rectal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT07450183Phase 2 · not yet recruiting Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1 · 50 trials list this drug (21 active)	—	—	Malignant Lung Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT03748485NA · recruiting Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis · 50 trials list this drug (21 active)	—	—	Malignant Colorectal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT07188025Phase 3 · recruiting ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer · 50 trials list this drug (21 active)	—	—	Malignant Rectal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT07413146NA · not yet recruiting Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial · 50 trials list this drug (21 active)	—	—	Malignant Colon Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02662504Phase 2 · completed Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma · 50 trials list this drug (21 active)	—	—	Pleural Malignant Mesothelioma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Paths